Surfactant without intubation in preterm infants with respiratory distress: First multi-center data;Surfactant ohne intubation bei frühgeborenen mit atemnotsyndrom: erste multizentrische daten

Klinische Padiatrie

Volumn 222, Issue 1, 2010, Pages 13-17

  Kribs, A ^a   Hartel C ^b   Kattner, E ^c   Vochem, M ^d   Kuster H ^e   Moller J ^f   Muller D ^g   Segerer, H ^h   Wieg, C ⁱ   Gebauer, C ^j   Nikischin, W ^b   Wense, A V D ^k   Herting, E ^b   Roth, B ^a   Gopel W ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Neonatologie   (Germany)

^d Neonatologie Kinderklinik Olgahospital   (United States)

^e UNIVERSITY OF GREIFSWALD   (Germany)

^f KLINIKUM SAARBRÜCKEN   (Germany)

^g KLINIKUM KASSEL   (Germany)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ Neonatologie   (Germany)

^j UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^k Altonaer Kinderkrankenhaus   (Germany)

more..

Author keywords

Bronchopulmonary dysplasia (BPD); Respiratory distress syndrome (RDS); Surfactant; Very low birth weight infant (VLBW infant)

Indexed keywords

ANALGESIC AGENT; CAFFEINE; CATECHOLAMINE; DEXAMETHASONE; DOXAPRAM; SURFACTANT; THEOPHYLLINE;

ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BRAIN HEMORRHAGE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HOSPITAL CARE; HUMAN; INFANT; INTERMETHOD COMPARISON; INTUBATION; LUNG DYSPLASIA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME;

BIOLOGICAL PRODUCTS; BRONCHOPULMONARY DYSPLASIA; COHORT STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INSTILLATION, DRUG; INTUBATION, INTRATRACHEAL; MALE; OXYGEN INHALATION THERAPY; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURVIVAL ANALYSIS;

EID: 76649141724     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1241867     Document Type: Article

References (22)

1. Aly H, etal. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics 2004 114 697-702
2. Ammari A, etal. Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 2005 147 341-347
3. Attar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol. 2002 7 (5) 353-360
4. Berggren E, etal. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr 2000 89 460-464
5. Booth C, etal. Sustainable use of continuous positive airway pressure in extremely preterm infants during the first week after delivery. Arch Dis Child 2006 91 F398-402
6. Brimacombe J, etal. The laryngeal mask airway for administration of surfactant in two neonates with respiratory distress syndrome. Pediatr Anaesth 2004 14 188-190
7. Donn SM, Sinha SK. Minimising ventilator induced lung injury in preterm infants. Arch Dis Child Fetal Neonatal Ed 2006 91 (3) F226-230
8. Finer N. To intubate or not that is the question: continuous positive airway pressure versus surfactant and extremely low birthweight infants. Arch Dis Child 2006 91 F392-394
9. Jorch G, etal. Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatr Pulmonol 1997 24 222-224
10. Kattwinkel J, etal. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol 2004 24 360-365
11. Kribs A, etal. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age 27 weeks). Paediatr Anaesth 2007 17 364-369
12. Kribs A, etal. Early surfactant in spontaneously breathing with nCPAP in ELBW infantsa single centre four year experience. Acta Paediatr 2008 97 (3) 293-298
13. Lindner U, etal. Drug utilisation in very preterm infants: Any Changes during the past decade? Klin Padiatr 2008 220 238-242
14. Loeliger M, etal. Cerebral outcomes in a preterm baboon model of early versus delayed nasal continuous positive airway pressure. Pediatrics 2006 118 1640-1653
15. Morley CJ, etal. COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008 358 (7) 700-708
16. Schmidt B, etal Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med 2006 18 2112-2121
17. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001 CD000510
18. Stevens TP, etal. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2004 CD003063
19. Strassburg HM, etal. Long-term prognosis of former very and extremely preterm babies in adulthood in Germany. Klin Padiatr 2008 220 61-65
20. Thomson MA, etal. Delayed extubation to nasal continuous positive airway pressure in the immature baboon model of bronchopulmonary dysplasia: Lung clinical and pathological findings. Pediatrics 2006 118 2038-2050
21. Trevisanuto D, etal. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate 2005 87 217-220
22. Van Marter LJ, etal. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000 105 1194-1201